[参考文献]　精神神経疾患と脂質代謝　
～スフィンゴ脂質をターゲットとした新たな治療戦略の可能性～

1. N. Bartke and Y. A. Hannun, J. Lipid Res., 2009, 50 Suppl, S91-96.
2. A. Penno et al., J. Biol. Chem., 2010, 285, 11178-11187.
3. S. Li et al., Nat. Struct. Mol. Biol., 2021, 28, 249-257.
4. R. J. Mead et al., Nat. Rev. Drug Discov., 2023, 22, 185-212.
5. P. Mohassel et al., Nat. Med., 2021, 27, 1197-1204.
6. H. Naruse et al., Ann. Clin. Transl. Neurol., 2024, 11, 946-957.
7. H. Bode et al., Hum. Mol. Genet., 2016, 25, 853-865.
8. I. Alecu et al., J. Lipid Res., 2017, 58, 42-59.
9. M. Bertea et al., Lipids Health Dis., 2010, 9, 84.
10. K. Esaki et al., J. Biol. Chem., 2015, 290, 14595-14609.
11. R. Kramer et al., FASEB J., 2015, 29, 4461-4472.
12. E. C. Del Re et al., Brain Imaging Behav., 2016, 10, 1264-1273.
13. I. Bendikov et al., Schizophr. Res., 2007, 90, 41-51.
14. S. Narayan and E. A. Thomas, Front Biosci. (Landmark Ed.), 2011, 16, 1797-1810.
15. K. Esaki et al., Schizophr. Bull., 2020, 46(5), 1172-1181.
16. A. Cartier and T. Hla, Science, 2019, 366, eaar5551.
17. J. Ceccom et al., Acta. Neuropathol. Commun., 2014, 2, 12.
18. T. A. Couttas et al., Acta. Neuropathol. Commun., 2014, 2, 9.
19. M. Sivasubramanian et al., Neuroscience, 2015, 290, 636-648.
20. A. Di Pardo et al., Sci. Rep., 2017, 7, 5280.